Brain Tumor Center
Great strides in translational research in neuro-oncology are leading the way at the NJNI laboratories, particularly in osmotic blood-brain barrier disruption— experimental treatment that uses different drugs to open blood vessels in the hopes of delivering more chemotherapeutic drugs across the blood-brain barrier and directly to the brain tumor. Additionally, new concepts are being tested and progress is being made in pain research and management of neuropathic pain, a significant complication in patients with tumors of the central nervous system. Current research is rapidly expanding our understanding of the pain syndromes with important implications for treatment in the future. Research studies are also being done to evaluate the genetic changes of brain and spinal tumors as well as the body’s autonomic responses to the tumor and its treatment.